Kyle Rose
Stock Analyst at Canaccord Genuity
(2.65)
# 2,008
Out of 5,130 analysts
115
Total ratings
53.76%
Success rate
13.54%
Average return
Main Sectors:
Stocks Rated by Kyle Rose
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PODD Insulet | Maintains: Buy | $432 → $450 | $289.04 | +55.69% | 17 | Dec 17, 2025 | |
| SNN Smith & Nephew | Maintains: Hold | $27 | $33.57 | -19.57% | 6 | Feb 26, 2025 | |
| SYK Stryker | Maintains: Buy | $420 → $435 | $367.54 | +18.35% | 20 | Jan 29, 2025 | |
| GMED Globus Medical | Maintains: Buy | $67 → $71 | $94.47 | -24.84% | 7 | Dec 20, 2023 | |
| ENOV Enovis | Maintains: Buy | $65 → $71 | $29.68 | +139.22% | 3 | Dec 20, 2023 | |
| INMD InMode | Downgrades: Hold | $55 → $22 | $14.44 | +52.35% | 10 | Oct 13, 2023 | |
| SKIN The Beauty Health Company | Assumes: Buy | $10 | $1.46 | +584.93% | 4 | Aug 25, 2023 | |
| ATEC Alphatec Holdings | Maintains: Buy | $17 → $22 | $22.65 | -2.87% | 4 | Aug 4, 2023 | |
| DXCM DexCom | Maintains: Buy | $135 → $150 | $67.40 | +122.55% | 17 | Jul 28, 2023 | |
| RBOT Vicarious Surgical | Maintains: Buy | $360 → $270 | $2.61 | +10,244.83% | 3 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $27 | $20.44 | +32.09% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.10 | +1,269.86% | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $33.51 | -55.24% | 6 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $125 → $122 | $165.98 | -26.50% | 1 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $3 → $4 | $5.65 | -29.20% | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $8.03 | - | 2 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $165 → $125 | $92.85 | +34.63% | 7 | Feb 8, 2022 |
Insulet
Dec 17, 2025
Maintains: Buy
Price Target: $432 → $450
Current: $289.04
Upside: +55.69%
Smith & Nephew
Feb 26, 2025
Maintains: Hold
Price Target: $27
Current: $33.57
Upside: -19.57%
Stryker
Jan 29, 2025
Maintains: Buy
Price Target: $420 → $435
Current: $367.54
Upside: +18.35%
Globus Medical
Dec 20, 2023
Maintains: Buy
Price Target: $67 → $71
Current: $94.47
Upside: -24.84%
Enovis
Dec 20, 2023
Maintains: Buy
Price Target: $65 → $71
Current: $29.68
Upside: +139.22%
InMode
Oct 13, 2023
Downgrades: Hold
Price Target: $55 → $22
Current: $14.44
Upside: +52.35%
The Beauty Health Company
Aug 25, 2023
Assumes: Buy
Price Target: $10
Current: $1.46
Upside: +584.93%
Alphatec Holdings
Aug 4, 2023
Maintains: Buy
Price Target: $17 → $22
Current: $22.65
Upside: -2.87%
DexCom
Jul 28, 2023
Maintains: Buy
Price Target: $135 → $150
Current: $67.40
Upside: +122.55%
Vicarious Surgical
May 31, 2023
Maintains: Buy
Price Target: $360 → $270
Current: $2.61
Upside: +10,244.83%
May 2, 2023
Maintains: Buy
Price Target: $24 → $27
Current: $20.44
Upside: +32.09%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $1.10
Upside: +1,269.86%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $33.51
Upside: -55.24%
Mar 1, 2023
Maintains: Market Perform
Price Target: $125 → $122
Current: $165.98
Upside: -26.50%
Nov 10, 2022
Upgrades: Buy
Price Target: $3 → $4
Current: $5.65
Upside: -29.20%
Nov 9, 2022
Downgrades: Hold
Price Target: n/a
Current: $8.03
Upside: -
Feb 8, 2022
Downgrades: Hold
Price Target: $165 → $125
Current: $92.85
Upside: +34.63%